Global Insight Services have recently published a report on Graft Versus Host Disease (GVHD) Pipeline landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Graft Versus Host disease (GVHD) is an immune mediated systemic disorder associated with complex interaction between donor and recipient adaptive immunity. It is a common complication after hematopoietic stem cell transplant (HCT), here the graft recognizes the host as a foreign and attack the recipient’s body cell. GvHD is of two types: acute GvHD – which develops within 100 days of transplantation and chronic GvHD – which develops after 100 days of transplantation.
GvHD occurs after the bone marrow transplants and stem cell transplants. Following are the other occurrences of GvHD – allogenic bone transplantation, solid organs that are rich in lymphoid cells and un-irradiated blood.
Symptoms of GvHD range from mild to severe. Common acute symptoms include abdominal pain or cramps, nausea, vomiting, diarrhoea, jaundice, skin rash, itching, redness on areas of the skin and increased risk for infections. Chronic symptoms include dry eyes, burning sensation, fatigue, joint pains, shortness of breath, wight loss, etc.,
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31106
Report Highlights
Global Insight Service’s, Graft Versus Host Disease (GVHD) – Drug Pipeline Landscape, 2022 report provides an overview of the Graft Versus Host Disease (GVHD) pipeline drugs. This report covers detailed insights on Graft Versus Host Disease (GVHD) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Graft Versus Host Disease (GVHD) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Ask For Customization : https://www.globalinsightservices.com/request-customization/GIS31106
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.
Report Segmentation
- Assessment by Stage of Development
- Assessment by Companies
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Molecule Type
- Assessment by Route of Administration
Some of the key players involved in development of Graft Versus Host Disease (GVHD) therapeutics are :
- 9 Meters Biopharma Inc
- Abbisko Cayman Limited
- Accro BioScience (Suzhou) Co Ltd
- Actitrexx GmbH
- Adienne Pharma & Biotech SA
- Alphamab Oncology
- AltruBio Inc
- Amcyte Pharma Inc
- AnaMar AB
- AnaptysBio Inc
- ASC Therapeutics Inc
- AstraZeneca Plc
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31106
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/